Variant report
Variant | nsv962239 |
---|---|
Chromosome Location | chr17:60377053-60392201 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:31)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:31 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr17:60383745-60383860 | HepG2 | liver: | n/a | chr17:60383834-60383847 chr17:60383836-60383847 chr17:60383834-60383845 |
2 | E2F4 | chr17:60385105-60385265 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | E2F4 | chr17:60381120-60381369 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr17:60386960-60387033 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr17:60388506-60388698 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOXA1 | chr17:60384568-60385030 | HepG2 | liver: | n/a | chr17:60384762-60384777 |
7 | FOXA1 | chr17:60384647-60384882 | HepG2 | liver: | n/a | chr17:60384762-60384777 |
8 | FOXA1 | chr17:60384514-60384926 | HepG2 | liver: | n/a | chr17:60384762-60384777 |
9 | FOXA1 | chr17:60384642-60384974 | HepG2 | liver: | n/a | chr17:60384762-60384777 |
10 | FOXA2 | chr17:60384674-60384859 | HepG2 | liver: | n/a | n/a |
11 | FOXA2 | chr17:60384595-60385077 | A549 | lung: | n/a | n/a |
12 | GATA3 | chr17:60384535-60385062 | MCF-7 | breast: | n/a | n/a |
13 | KAP1 | chr17:60384608-60385164 | HEK293 | kidney: | n/a | n/a |
14 | KAP1 | chr17:60384640-60384918 | U2OS | brain: | n/a | n/a |
15 | MAFK | chr17:60380938-60381157 | HepG2 | liver: | n/a | n/a |
16 | MAFK | chr17:60380917-60381128 | HepG2 | liver: | n/a | n/a |
17 | MYC | chr17:60386887-60387088 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | NFYA | chr17:60386742-60386929 | GM12878 | blood: | n/a | n/a |
19 | NR2F2 | chr17:60384430-60384967 | MCF-7 | breast: | n/a | n/a |
20 | POLR2A | chr17:60381244-60381425 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | POLR2A | chr17:60385084-60385415 | H1-neurons | neurons: | n/a | n/a |
22 | POLR2A | chr17:60378073-60378139 | ProgFib | skin: | n/a | n/a |
23 | POLR2A | chr17:60385036-60385441 | H1-neurons | neurons: | n/a | n/a |
24 | REST | chr17:60385034-60385395 | H1-neurons | neurons: | n/a | n/a |
25 | STAT3 | chr17:60386913-60386936 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | STAT3 | chr17:60377680-60377869 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | STAT3 | chr17:60386552-60386628 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | STAT3 | chr17:60386947-60387064 | MCF10A-Er-Src | breast: | n/a | chr17:60387044-60387055 |
29 | STAT3 | chr17:60387091-60387111 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | TCF7L2 | chr17:60384543-60384896 | HEK293 | kidney: | n/a | n/a |
31 | ZNF263 | chr17:60387225-60387466 | HEK293-T-REx | kidney: | n/a | chr17:60387380-60387401 |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:102756121..102758163-chr17:60389261..60390875,2 | MCF-7 | breast: | |
2 | chr17:60376068..60377977-chr17:60387444..60389081,2 | MCF-7 | breast: | |
3 | chr17:60378073..60380516-chr17:60388051..60389639,2 | MCF-7 | breast: | |
4 | chr17:60387371..60389325-chr17:60391804..60394700,2 | MCF-7 | breast: | |
5 | chr17:60378073..60380516-chr17:60388051..60389639,2 | MCF-7 | breast: | |
6 | chr17:60387132..60388706-chr17:60393027..60395897,2 | K562 | blood: | |
7 | chr17:60376068..60377977-chr17:60387444..60389081,2 | MCF-7 | breast: | |
8 | chr17:60387371..60389325-chr17:60391804..60394700,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AC053481.1-2 | chr17:60384813-60385182 | ncRnaDb_ncrna_FR286847_1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000263887 | TF binding region |
ENSG00000107816 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528090505 | chr17:60377856-60377857 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs374116063 | chr17:60378075-60378076 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs566038284 | chr17:60378090-60378091 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs75870878 | chr17:60378094-60378095 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs186406719 | chr17:60378099-60378100 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs529256080 | chr17:60384843-60384844 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs541633986 | chr17:60384866-60384867 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs564490350 | chr17:60384867-60384868 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs533690733 | chr17:60384875-60384876 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs550251394 | chr17:60384907-60384908 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs570352038 | chr17:60384910-60384911 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs529338240 | chr17:60384953-60384954 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs73329403 | chr17:60384968-60384969 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs113375800 | chr17:60384997-60384998 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs200872451 | chr17:60384998-60384999 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs10642716 | chr17:60385006-60385007 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs10642717 | chr17:60385007-60385008 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs10682823 | chr17:60385029-60385030 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs375855811 | chr17:60385031-60385032 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs566199490 | chr17:60385072-60385073 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs185874147 | chr17:60385075-60385076 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs550738189 | chr17:60385090-60385091 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs28716486 | chr17:60385092-60385093 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs374753855 | chr17:60385123-60385124 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs570506420 | chr17:60385133-60385134 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs539617128 | chr17:60385141-60385142 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs556079051 | chr17:60385159-60385160 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs575916852 | chr17:60385203-60385204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs116767748 | chr17:60385262-60385263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73992015 | chr17:60385293-60385294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs139826833 | chr17:60385312-60385313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs8080209 | chr17:60385358-60385359 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs564708715 | chr17:60385362-60385363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs578137464 | chr17:60385396-60385397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs75800343 | chr17:60385419-60385420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370698832 | chr17:60385496-60385497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs36008948 | chr17:60385583-60385584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563996892 | chr17:60385591-60385592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574329967 | chr17:60386613-60386614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544989132 | chr17:60386628-60386629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542685590 | chr17:60386647-60386648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs193092343 | chr17:60386673-60386674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553424725 | chr17:60386686-60386687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573461196 | chr17:60386692-60386693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368896067 | chr17:60386801-60386802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184159250 | chr17:60386803-60386804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146320326 | chr17:60386822-60386823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187543034 | chr17:60386847-60386848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs62069149 | chr17:60386860-60386861 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs79510651 | chr17:60386876-60386877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
Chordoma | 18071362 | CNVD |
Cancer | 16751803 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 21523713 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21858162 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
XY sex reversal | 17503084 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17899364 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 16620391 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21611746 | CNVD |
Williams-Beuren syndrome | 16971481 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
Cancer | 21129771 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:60384800-60385600 | Enhancers | Fetal Intestine Small | intestine |
2 | chr17:60385000-60385200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr17:60385000-60385400 | Enhancers | Fetal Intestine Large | intestine |
4 | chr17:60385000-60385400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
5 | chr17:60386600-60387200 | Enhancers | NHEK | skin |
6 | chr17:60387200-60387600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |